1. Home
  2. BLRX vs HKIT Comparison

BLRX vs HKIT Comparison

Compare BLRX & HKIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLRX
  • HKIT
  • Stock Information
  • Founded
  • BLRX 2003
  • HKIT 1996
  • Country
  • BLRX Israel
  • HKIT China
  • Employees
  • BLRX N/A
  • HKIT N/A
  • Industry
  • BLRX Biotechnology: Pharmaceutical Preparations
  • HKIT Computer Software: Prepackaged Software
  • Sector
  • BLRX Health Care
  • HKIT Technology
  • Exchange
  • BLRX Nasdaq
  • HKIT Nasdaq
  • Market Cap
  • BLRX 54.1M
  • HKIT 45.4M
  • IPO Year
  • BLRX 2011
  • HKIT 2023
  • Fundamental
  • Price
  • BLRX $0.46
  • HKIT $1.45
  • Analyst Decision
  • BLRX Strong Buy
  • HKIT
  • Analyst Count
  • BLRX 2
  • HKIT 0
  • Target Price
  • BLRX $11.50
  • HKIT N/A
  • AVG Volume (30 Days)
  • BLRX 314.6K
  • HKIT 33.1K
  • Earning Date
  • BLRX 11-18-2024
  • HKIT 11-07-2024
  • Dividend Yield
  • BLRX N/A
  • HKIT N/A
  • EPS Growth
  • BLRX N/A
  • HKIT N/A
  • EPS
  • BLRX N/A
  • HKIT 0.08
  • Revenue
  • BLRX $17,048,000.00
  • HKIT $4,563,731.00
  • Revenue This Year
  • BLRX N/A
  • HKIT N/A
  • Revenue Next Year
  • BLRX N/A
  • HKIT N/A
  • P/E Ratio
  • BLRX N/A
  • HKIT $18.73
  • Revenue Growth
  • BLRX N/A
  • HKIT N/A
  • 52 Week Low
  • BLRX $0.43
  • HKIT $0.54
  • 52 Week High
  • BLRX $1.93
  • HKIT $6.48
  • Technical
  • Relative Strength Index (RSI)
  • BLRX 26.70
  • HKIT 47.77
  • Support Level
  • BLRX $0.43
  • HKIT $1.39
  • Resistance Level
  • BLRX $0.56
  • HKIT $1.79
  • Average True Range (ATR)
  • BLRX 0.05
  • HKIT 0.12
  • MACD
  • BLRX -0.01
  • HKIT 0.01
  • Stochastic Oscillator
  • BLRX 12.42
  • HKIT 22.99

About BLRX BioLineRx Ltd.

BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.

About HKIT Hitek Global Inc.

Hitek Global Inc is a provider of information technology consulting and solutions services. The company has two lines of businesses such as services to small and medium businesses, which consist of Anti-Counterfeiting Tax Control System tax devices, including Golden Tax Disk and printers, ACTCS services, and IT services; and services to large businesses, which include hardware sales and software sales. It generates revenues from hardware sales, software sales, IT services, and tax devices and services.

Share on Social Networks: